Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Emer Cooke Prepares To Take Over As Head Of EMA

New Executive Director Is Due To Start Mid-November

Executive Summary

The change in leadership at the European Medicines Agency comes at a critical time.

You may also be interested in...



Emer Cooke Nominated To Lead EMA

The European Medicines Agency has made its choice for a new executive director.

Two In Running For Top Job At EMA

A new executive director will be chosen for the European Medicines Agency on 25 June. The agency's management board has two candidates from which to choose.

EMA Unveils Revamped Human Medicines Unit

Europe’s top drugs regulator has reorganized its operations to tackle what it calls “fundamental changes” brought by new legislative initiatives, digital technologies, global trends in science, and staff losses due to Brexit. More changes are to be implemented during the course of 2020 in a bid to optimize the agency’s regulatory and scientific output.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS143136

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel